Creon 40,000 for Treatment of PEI (Pancreatic Exocrine Insufficiency) Due to Chronic Pancreatitis
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
This study will provide efficacy data for Creon 40,000 in CP subjects as well as long-term
safety data. During the long-term treatment with Creon 40,000 nutritional parameters will be
assessed and correlated with CFA.